CU6 0.48% $6.22 clarity pharmaceuticals ltd

The copper SAR chelator won't hold onto actinium (at least not...

  1. 19,115 Posts.
    lightbulb Created with Sketch. 5959
    The copper SAR chelator won't hold onto actinium (at least not well) and they will probably be using a different chelator, but this is not what makes CU6 special. The real value is in the bis-PSMA construct - copper is clever, the SAR chelator is good, the real genius is in the dual-PSMA binding ligands. This can (in theory) be applied to any isotope or chelator.

    I really wish Alan would dumb these announcements down for the Australian market. This announcement that has far too much assumed knowledge - anyway for those that understand what we have just been told this is a good buying opportunity.
    Last edited by Davisite: 17/07/24
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$6.22
Change
0.030(0.48%)
Mkt cap ! $1.959B
Open High Low Value Volume
$6.22 $6.35 $6.20 $5.199M 827.0K

Buyers (Bids)

No. Vol. Price($)
1 442 $6.22
 

Sellers (Offers)

Price($) Vol. No.
$6.27 5000 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.